These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 21922466)

  • 1. The thymus in myasthenia gravis: Site of "innate autoimmunity"?
    Cavalcante P; Le Panse R; Berrih-Aknin S; Maggi L; Antozzi C; Baggi F; Bernasconi P; Mantegazza R
    Muscle Nerve; 2011 Oct; 44(4):467-84. PubMed ID: 21922466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune mechanisms in myasthenia gravis.
    Cavalcante P; Bernasconi P; Mantegazza R
    Curr Opin Neurol; 2012 Oct; 25(5):621-9. PubMed ID: 22941261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune diseases against cell surface receptors: myasthenia gravis, a prototype anti-receptor disease.
    De Baets MH
    Neth J Med; 1994 Dec; 45(6):294-301. PubMed ID: 7838246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
    Hohlfeld R; Wekerle H
    J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis.
    Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
    Huang GZ; Lo YL
    J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thymic abnormalities in patients with myasthenia gravis].
    Utsugisawa K; Nagane Y
    Brain Nerve; 2011 Jul; 63(7):685-94. PubMed ID: 21747138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biological heterogeneity of autoimmune myasthenia gravis.
    Pal J; Rozsa C; Komoly S; Illes Z
    J Neuroimmunol; 2011 Feb; 231(1-2):43-54. PubMed ID: 21093931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
    Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
    J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
    Meinl E; Klinkert WE; Wekerle H
    Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis, a model of organ-specific autoimmune disease.
    Berrih-Aknin S
    J Autoimmun; 1995 Apr; 8(2):139-43. PubMed ID: 7612144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights in the autoimmunity of myasthenia gravis.
    De Baets MH
    Autoimmunity; 2010 Aug; 43(5-6):341-3. PubMed ID: 20380585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology of myasthenia gravis: innate immunity signature in pathological thymus.
    Cavalcante P; Cufi P; Mantegazza R; Berrih-Aknin S; Bernasconi P; Le Panse R
    Autoimmun Rev; 2013 Jul; 12(9):863-74. PubMed ID: 23535157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes.
    Marx A; Pfister F; Schalke B; Saruhan-Direskeneli G; Melms A; Ströbel P
    Autoimmun Rev; 2013 Jul; 12(9):875-84. PubMed ID: 23535159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
    Corey AL; Richman DP; Agius MA; Wollmann RL
    J Immunol; 1987 May; 138(10):3269-75. PubMed ID: 3494763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients.
    Navaneetham D; Penn AS; Howard JF; Conti-Fine BM
    J Autoimmun; 1998 Dec; 11(6):621-33. PubMed ID: 9878084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.